These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3713924

  • 1. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
    Adwankar MK, Chitnis MP.
    Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.
    Chitnis M, Adwankar M.
    Tumori; 1986 Oct 31; 72(5):469-73. PubMed ID: 3798566
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells.
    Chitnis M, Juvekar A, Adwankar M, Advani S.
    Anticancer Res; 1986 Oct 31; 6(4):749-51. PubMed ID: 3463243
    [Abstract] [Full Text] [Related]

  • 4. Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
    Juvekar AS, Chitnis MP.
    Neoplasma; 1991 Oct 31; 38(2):207-11. PubMed ID: 2041579
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
    Ning SC, Hahn GM.
    Cancer Res; 1991 Nov 01; 51(21):5910-4. PubMed ID: 1718588
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antitumor activity and toxicity in mice of RA-700, a cyclic hexapeptide.
    Kato T, Suzumura Y, Takamoto S, Ota K.
    Anticancer Res; 1987 Nov 01; 7(3 Pt B):329-34. PubMed ID: 3631886
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin.
    Zupi G, Greco C, Laudonio N, Benassi M, Silvestrini B, Caputo A.
    Anticancer Res; 1986 Nov 01; 6(5):1245-9. PubMed ID: 3800331
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
    Robins HI, Longo WL, Lagoni RK, Neville AJ, Hugander A, Schmitt CL, Riggs C.
    Cancer Res; 1988 Nov 15; 48(22):6587-92. PubMed ID: 3180069
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancement of the in vitro cytotoxicity of bouvardin by verapamil alone and combined with hyperthermia in Sarcoma 180 and Ehrlich ascites carcinoma cells.
    Chitnis MP, Adwankar MK.
    J Cancer Res Clin Oncol; 1986 Nov 15; 112(2):131-4. PubMed ID: 3771622
    [Abstract] [Full Text] [Related]

  • 16. Combined effects of lonidamine and hyperthermia on malignant melanoma and lung carcinoma surgical specimens.
    Zaffaroni N, Villa R, Orlandi L, Vaglini M, Silvestrini R.
    Anticancer Res; 1992 Nov 15; 12(1):247-50. PubMed ID: 1314533
    [Abstract] [Full Text] [Related]

  • 17. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb 15; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

  • 18. Reversal of natural resistance to bouvardin (NSC 259968) in sarcoma 180 cells in vitro and in vivo by verapamil.
    Chitnis MP, Menon RS, Basrur VS, Adwankar MK, Satyamoorthy K.
    J Cancer Res Clin Oncol; 1985 Feb 15; 110(3):221-4. PubMed ID: 4077920
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of P388 murine leukemia cells to hydroxyurea cytotoxicity by hydrophobic iron-chelating agents.
    Satyamoorthy K, Chitnis M, Basrur V.
    Anticancer Res; 1986 Feb 15; 6(2):329-33. PubMed ID: 3518597
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.